Why Is Estratest So Hard to Find? [Explained for 2026]

You've been on Estratest for years — or maybe you're newly prescribed — and suddenly your pharmacy says they don't have it. You call another. Same answer. You try a third. Nothing. If this sounds familiar, you're not alone.

Estratest (esterified estrogens/methyltestosterone) has become one of the more frustrating medications to fill in 2026. It's not impossible to find, but it takes effort — and knowing why it's hard to locate can help you solve the problem faster. Let's break it all down.

What Is Estratest?

Estratest is a combination hormone therapy that pairs esterified estrogens with methyltestosterone — a synthetic testosterone — in a single oral tablet. It was originally marketed as a prescription medication for postmenopausal women experiencing moderate to severe hot flashes and night sweats that didn't improve with estrogen-only therapy.

The medication comes in two strengths:

Estratest F.S. (full strength): 1.25 mg esterified estrogens / 2.5 mg methyltestosterone

Estratest H.S. (half strength): 0.625 mg esterified estrogens / 1.25 mg methyltestosterone

It's taken in cycles — typically 3 weeks on and 1 week off — and is considered a second-line option for menopause management after estrogen-only therapies haven't provided adequate relief.

Because it contains methyltestosterone, an anabolic steroid, this medication is classified under DEA regulations as a controlled substance for many formulations — which turns out to be one of the key reasons it can be hard to find.

Is the Estratest Brand Still Available?

The original Estratest brand — made by Solvay Pharmaceuticals — was discontinued in March 2009. Solvay cited a variety of business factors and stopped accepting new orders at the end of March 2009. This was a major supply disruption for patients who had relied on the brand for years.

However, the underlying medication — esterified estrogens/methyltestosterone — did not disappear entirely. Generic versions remain available under different brand names including Covaryx, Covaryx HS, EEMT, EEMT HS, Essian, Syntest, and Menogen. Some of these have also come and gone from the market. In practice, most patients today fill a generic labeled simply as "esterified estrogens/methyltestosterone" or EEMT.

So yes — you can still get this medication, but you may be getting a generic rather than the old Estratest brand. Ask your pharmacist which manufacturer's version they carry, as the available product can change depending on the pharmacy's supplier.

Why Is Estratest So Hard to Find in 2026?

There are several overlapping reasons this medication is so difficult to locate. Understanding all of them gives you more options for solving the problem.

Reason 1: Very Few Manufacturers Make It

Unlike popular generic medications that may be manufactured by dozens of different companies, esterified estrogens/methyltestosterone is produced by only a small number of generic drug manufacturers. When one of those manufacturers faces a production delay, quality issue, or supply chain disruption, there's very little backup capacity to absorb the shortfall. Patients at pharmacies across the country feel it immediately.

Reason 2: DEA Controlled Substance Regulations Add Complexity

Because the medication contains methyltestosterone — a controlled substance — manufacturers face additional regulatory requirements from the Drug Enforcement Administration (DEA). These include production quotas, enhanced record-keeping, and stricter storage and distribution requirements. These regulatory hurdles can slow production timelines and limit how quickly manufacturers can ramp up supply in response to demand.

From a pharmacy standpoint, controlled substances also require special storage, documentation, and reporting — adding cost and complexity to stocking this medication.

Reason 3: It Serves a Small, Niche Patient Population

Estratest/EEMT is not a first-line menopause treatment. It's specifically for postmenopausal women who haven't gotten adequate relief from estrogen-only therapy — a subset of an already-defined patient population. This smaller market makes the medication less profitable for manufacturers to produce at high volumes and less attractive for pharmacies to keep as a routinely stocked item. The result is a classic supply problem: lower demand drives lower stocking, which creates shortages for the patients who genuinely need it.

Reason 4: The Medication's Regulatory History Creates Confusion

Estratest was brought to market in 1964 — before the modern FDA drug approval system was fully established. It has never received formal FDA approval through the New Drug Application (NDA) process, which has created ongoing regulatory questions about its status. The FDA has previously stated it does not believe there is substantial evidence that the androgen component contributes to effectiveness in combination. This uncertainty has led some prescribers to be cautious about prescribing it and some pharmacies to be uncertain about stocking it.

Is Estratest in a Nationwide Shortage?

Estratest and its generic equivalents are not currently listed on the FDA's official drug shortage list. However, patients and pharmacists consistently report difficulty locating it — particularly in specific regions or at certain pharmacy chains. This is what we call an intermittent, localized supply issue rather than a formal nationwide shortage.

The practical effect for patients is the same: your local pharmacy may be out of stock, and finding a pharmacy that carries it may require calling around. The difference is that some pharmacies do have it — you just have to find them.

What Can You Do If Your Pharmacy Doesn't Have Estratest?

Here are practical steps you can take right now:

Specify the strength you need. When calling pharmacies, specify whether you need full strength (1.25 mg/2.5 mg) or half strength (0.625 mg/1.25 mg). Some pharmacies carry one but not the other.

Ask about all generic versions. Ask the pharmacist to check for EEMT, EEMT HS, Covaryx, and other generics — not just Estratest by name.

Try independent pharmacies. Independent and compounding pharmacies sometimes carry or can source medications that chain pharmacies don't stock routinely.

Consider mail-order. Mail-order pharmacies through your insurance often maintain larger inventories than retail pharmacies. Ask your insurance company for mail-order options.

Use medfinder. medfinder calls pharmacies near you to check which ones have your specific medication and dose in stock — so you don't have to make all those phone calls yourself.

What If Estratest Is Truly Unavailable Near You?

If you've genuinely exhausted all local options, talk to your prescriber about alternatives. Options like estradiol (Estrace, Climara, Vivelle-Dot), Premarin, Prempro, or Bijuva may be more widely available and could manage your symptoms effectively. Read our full guide on alternatives to Estratest for a detailed comparison.

Never stop hormone therapy abruptly without consulting your doctor — a managed transition to an alternative is the safest approach.

The Bottom Line

Estratest is hard to find in 2026 because of a combination of factors: brand discontinuation, limited generic manufacturers, DEA regulatory requirements, and a smaller patient population. It's not a formal nationwide shortage, but the practical impact on patients is very real. The good news: the medication does exist as a generic, and with the right approach — calling ahead, asking about all generic names, and using tools like medfinder — you can usually find it.

For step-by-step strategies on locating Estratest near you, see our guide: How to Find Estratest In Stock Near You (Tools + Tips).